170 related articles for article (PubMed ID: 21794774)
1. [Rheumatology and osteoporosis (RETOSS): a vision of postmenopausal osteoporosis in rheumatology departments throughout Spain].
Bernad Pineda M; González Fernández CM; Fernández Prada M; Fernández Campillo J; Maeso Martín R; Garcés Puentes MV
Reumatol Clin; 2011; 7(1):13-9. PubMed ID: 21794774
[TBL] [Abstract][Full Text] [Related]
2. The relationship between back pain and future vertebral fracture in postmenopausal women.
Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T
Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106
[TBL] [Abstract][Full Text] [Related]
3. [Postmenopausal osteoporosis: clinical characteristics in patients first vertebral crush fracture. Results of the GRIO National Multicenter Survey. Groupe de Recherche et d'Information sur les Osteoporoses].
Ribot C; Pouillès JM
Rev Rhum Ed Fr; 1993 Jun; 60(6):427-34. PubMed ID: 8124276
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.
Liberman UA; Weiss SR; Bröll J; Minne HW; Quan H; Bell NH; Rodriguez-Portales J; Downs RW; Dequeker J; Favus M
N Engl J Med; 1995 Nov; 333(22):1437-43. PubMed ID: 7477143
[TBL] [Abstract][Full Text] [Related]
5. Disc space narrowing is associated with an increased vertebral fracture risk in postmenopausal women: the OFELY Study.
Sornay-Rendu E; Munoz F; Duboeuf F; Delmas PD;
J Bone Miner Res; 2004 Dec; 19(12):1994-9. PubMed ID: 15537442
[TBL] [Abstract][Full Text] [Related]
6. Incidence of fragility fractures.
Tarantino U; Cannata G; Lecce D; Celi M; Cerocchi I; Iundusi R
Aging Clin Exp Res; 2007 Aug; 19(4 Suppl):7-11. PubMed ID: 18182886
[TBL] [Abstract][Full Text] [Related]
7. Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study.
McCloskey E; Selby P; Davies M; Robinson J; Francis RM; Adams J; Kayan K; Beneton M; Jalava T; Pylkkänen L; Kenraali J; Aropuu S; Kanis JA
J Bone Miner Res; 2004 May; 19(5):728-36. PubMed ID: 15068495
[TBL] [Abstract][Full Text] [Related]
8. Lactose intolerance: a risk factor for reduced bone mineral density and vertebral fractures?
Kudlacek S; Freudenthaler O; Weissböeck H; Schneider B; Willvonseder R
J Gastroenterol; 2002; 37(12):1014-9. PubMed ID: 12522532
[TBL] [Abstract][Full Text] [Related]
9. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
Seibel MJ; Naganathan V; Barton I; Grauer A
J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
[TBL] [Abstract][Full Text] [Related]
10. Vertebral fracture risk reduction with strontium ranelate in women with postmenopausal osteoporosis is independent of baseline risk factors.
Roux C; Reginster JY; Fechtenbaum J; Kolta S; Sawicki A; Tulassay Z; Luisetto G; Padrino JM; Doyle D; Prince R; Fardellone P; Sorensen OH; Meunier PJ
J Bone Miner Res; 2006 Apr; 21(4):536-42. PubMed ID: 16598373
[TBL] [Abstract][Full Text] [Related]
11. Clinical grading of spinal osteoporosis: quality of life components and spinal deformity in women with chronic low back pain and women with vertebral osteoporosis.
Leidig-Bruckner G; Minne HW; Schlaich C; Wagner G; Scheidt-Nave C; Bruckner T; Gebest HJ; Ziegler R
J Bone Miner Res; 1997 Apr; 12(4):663-75. PubMed ID: 9101379
[TBL] [Abstract][Full Text] [Related]
12. Functional status and prevalence of falls and fractures in population-based sample of postmenopausal women from the RAC-OST-POL Study.
Drozdzowska B; Wiktor K; Pluskiewicz W
Int J Clin Pract; 2013 Jul; 67(7):673-81. PubMed ID: 23758446
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and Older: results from the National Osteoporosis Risk Assessment (NORA).
Siris ES; Brenneman SK; Miller PD; Barrett-Connor E; Chen YT; Sherwood LM; Abbott TA
J Bone Miner Res; 2004 Aug; 19(8):1215-20. PubMed ID: 15231007
[TBL] [Abstract][Full Text] [Related]
14. Comparison of fracture, cardiovascular event, and breast cancer rates at 3 years in postmenopausal women with osteoporosis.
Silverman SL; Delmas PD; Kulkarni PM; Stock JL; Wong M; Plouffe L
J Am Geriatr Soc; 2004 Sep; 52(9):1543-8. PubMed ID: 15341559
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for fractures of the proximal humerus: results from the EPIDOS prospective study.
Lee SH; Dargent-Molina P; Bréart G;
J Bone Miner Res; 2002 May; 17(5):817-25. PubMed ID: 12009012
[TBL] [Abstract][Full Text] [Related]
17. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
Siris ES; Baim S; Nattiv A
Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
[TBL] [Abstract][Full Text] [Related]
18. Characterization of patients with an inadequate clinical outcome from osteoporosis therapy: the Observational Study of Severe Osteoporosis (OSSO).
Jakob F; Marín F; Martín-Mola E; Torgerson D; Fardellone P; Adami S; Thalassinos NC; Sykes D; Melo-Gomes J; Chinn C; Nicholson T; Cooper C
QJM; 2006 Aug; 99(8):531-43. PubMed ID: 16861718
[TBL] [Abstract][Full Text] [Related]
19. [Epidemiology of osteoporosis].
Bonjour JP; Burckhardt P; Dambacher M; Kraenzlin ME; Wimpfheimer C
Schweiz Med Wochenschr; 1997 Apr; 127(16):659-67. PubMed ID: 9198892
[TBL] [Abstract][Full Text] [Related]
20. Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS).
Roy DK; O'Neill TW; Finn JD; Lunt M; Silman AJ; Felsenberg D; Armbrecht G; Banzer D; Benevolenskaya LI; Bhalla A; Bruges Armas J; Cannata JB; Cooper C; Dequeker J; Diaz MN; Eastell R; Yershova OB; Felsch B; Gowin W; Havelka S; Hoszowski K; Ismail AA; Jajic I; Janott I; Johnell O; Kanis JA; Kragl G; Lopez Vaz A; Lorenc R; Lyritis G; Masaryk P; Matthis C; Miazgowski T; Gennari C; Pols HA; Poor G; Raspe HH; Reid DM; Reisinger W; Scheidt-Nave C; Stepan JJ; Todd CJ; Weber K; Woolf AD; Reeve J;
Osteoporos Int; 2003 Jan; 14(1):19-26. PubMed ID: 12577181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
